Fudan Zhangjiang (688505): High competition barriers for core products of leading international companies in photodynamic technology
長城國瑞證券Nov 25, 2020 00:00
Fudan Zhangjiang (688505) IPO Report: Photodynamic and Nanopharmaceutical Leaders Can Be Expected to Develop in the Future
興業證券Jun 22, 2020 00:00
Zhang Jiang, Fudan (688505): the purchase Strategy of Science and Technology Innovation Board's New shares
申萬宏源研究Jun 3, 2020 00:00
Fudan Zhangjiang (688505): inquiry Strategy of Science and Technology Board
國泰君安Jun 2, 2020 00:00
Fudan Zhangjiang (1349.HK): an innovative pharmaceutical company characterized by photodynamic drugs
西南證券Mar 10, 2019 00:00
Fudan Zhangjiang (01349.HK) Annual report comments: the growth rate of core varieties slows down and the listing of new products becomes a new increment.
興業證券Mar 17, 2017 00:00
Fudan Zhangjiang (1349.HK) research report: outstanding R & D capabilities of new products are expected to drive accelerated growth
興業證券Dec 14, 2016 00:00
Fudan Zhangjiang (1349.HK) comments: the R & D-based business model brings a premium for shares
銀河國際Jan 6, 2016 00:00
Deutsche Bank reassesses the purchase of Fudan Zhangjiang (01349.HK), and the target price rises to HK$10.7
德意志銀行Jun 1, 2015 15:46
Fudan Zhangjiang (1349.HK) Research brief: the product has obvious advantages in technological innovation.
國元(香港)May 16, 2014 00:00
Fudan Zhang Jiang (1349.HK) Research Notes
國元(香港)Dec 18, 2013 00:00
Zhang Jiang, Fudan (08231.HK): Focus on R&D or grow into China's “Anjin” in the future
國泰君安國際Oct 10, 2013 00:00
Fudan Zhangjiang (08231.HK) Investment Value Analysis Report: Innovative Biomedical Enterprises Transforming to Industrialization
中信證券國際Nov 26, 2012 00:00
No Data
No Data